Risk factors
Celularity (CELU) risk factors
Item 1A of every Celularity Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors77 risks2 new6 dropped5 reworded
Continued workforce reductions create execution and operational-continuity concerns.
Filed Apr 30, 2026 - FY2024 10-K risk factors81 risks
Celularity faces going concern doubts with $0.7 million in cash as of December 31, 2024, and no approved cellular therapeutics. The company relies heavily on its Florham Park, New Jersey facility and placental-derived allogeneic cell therapies.
Filed May 08, 2025